Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2022-09-14 00:00:00 ET · period of report 2022-09-12 · accession 0001415889-22-009623 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-14 | 2022-09-12 | ANIP | Davis Krista | SVP, Chief HR Off | A - Grant | $0.00 | +16.4K | 16.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-12 | A | A | 16,433 | $0.00 | 16,433 | D | — | — |